Signaling pathways
-
BA5516 AnisodamineSummary: Anisodamine (6-Hydroxyhyoscyamine), belladonna alkaloid, is also a non-subtype-selective muscarinic and nicotinic cholinergic receptor antagonist. - BA5517 AC260584Summary: AC260584 is a muscarinic receptor variant agonist.
- BA5518 ML381Summary: ML381 (VU0488130) is a highly selective
- BA5519 FesoterodineSummary: Fesoterodine is an orally effective, non-subtype-selective, competitive muscarinic receptor antagonist.
- BA5520 ZamifenacinSummary: Zamifenacin (UK-76654) is a potent intestinal selective muscarinic receptor antagonist.
- BA5521 NuvenzepineSummary: Nuvenzepine is an antagonist.
- BA5522 AnagyrineSummary: Anagyrine ((-)-Anagyrine) is a quinoline alkaloid.
- BA5523 VU6000918Summary: VU6000918 is a muscarinic acetylcholine-positive variable modulator.
- BA5525 VU0152099Summary: VU0152099 is a potent, selective and orthosteric modulator that crosses the blood-brain barrier.
- BA5526 DexetimideSummary: Dexetimide ((+)-Benzetimide; (S)-(+)-Dexetimide; Dexbenzetimide) is a piperidine anticholinergic and a muscarinic receptor antagonist with high affinity.